New waist size cutoff: 94 cm Men, 80 Women, less for South Asians

The smaller the waistline the better especially for those with
metabolic syndrome (MetS) which includes everyone with type-2 diabetes.

May GOD continue to heal our hearts with HIS living water so that we
can love others just a little bit more, dear brother Enrico whom I love
unconditionally.

Prayerfully in Christ's amazing love,

Andrew
--
Andrew B. Chung
Cardiologist, Atlanta, Georgia, USA
http://HeartMDPhD.com/HolySpirit

As for knowing who are the very elect, these you will know by the
unconditional love they have for everyone including their enemies
(Matthew 5:44-45, 1 Corinthians 13:3, James 2:14-17).
http://HeartMDPhD.com/Love


Enrico C wrote:
94cm = 37inches
80cm = 31/32inches


What do you make of this...?

http://www.ucdmc.ucdavis.edu/ome/mcr...definition.pdf

The metabolic syndrome—a new worldwide definition
[...]
The International Diabetes Federation (IDF) felt there
was a strong need for one practical definition that would
be useful in any country for the identification of people at
high risk of CVD, but also diabetes. This definition would
also allow comparative long-term studies, which could
then be used, if necessary, to refine the definition on the
basis of solid endpoints. As a result, an IDF consensus
group met in 2004, with representatives from the
organisations that had generated the previous definitions
and members from all IDF regions. Their recommenda-
tions are now available.
[...]
Central obesity, as assessed by waist circumference, was
agreed as essential (panel), because of the strength of the
evidence linking waist circumference with cardiovascular
disease and the other metabolic syndrome components,
and the likelihood that central obesity is an early step in
the aetiological cascade leading to full metabolic
syndrome. The waist circumference cutoff selected was
the same as that used by European Group for the Study of
Insulin Resistance, and lower than the main Adult
Treatment Panel III recommendations, because most
available data suggest an increase in other cardiovascular
disease risk factors in Europids (white people of European
origin, regardless of where they live in the world) when
the waist circumference rises above 94 cm in men and
80cm in women. Ethnic-specific waist circumference
cutoffs have been incorporated into the definition (table),
and have been based on available data linking waist
circumference to other components of the metabolic
syndrome in different populations. The levels of the
other variables were as described by Adult Treatment
Panel III, except that the most recent diagnostic level from
the American Diabetes Association for impaired fasting
glucose (5·6 mmol/L [100 mg/dL]) was used. Although
this new definitionwill still miss substantial numbers of
people with impaired glucose tolerance (because an oral
glucose-tolerance test is not required), it retains the
simplicity of the instrument.
The consensus group also recommended additional
criteria that should be part of further research into
metabolic syndrome, including: tomographic assessment
of visceral adiposity and liver fat, biomarkers of adipose
tissue (adiponectin, leptin), apolipoprotein B, LDL particle
size, formal measurement of insulin resistance and an oral
glucose-tolerance test, endothelial dysfunction, urinary
albumin, inflammatory markers (C-reactive protein,
tumour necrosis factor , interleukin 6), and thrombotic
markers (plasminogen activator inhibitor type 1,
fibrinogen). These factors should be combined with
assessment of CVD outcome and development of
diabetes so better predictors can be developed.
Researchers and clinicians should use the new criteria
for the identification of high-risk individuals and for
research studies. Preventive measures are obviously
needed in the people identified. Mounting evidence
suggests that lifestyle modification with weight loss and
increased physical activity will be beneficial, although
specific studies in metabolic syndrome are needed.
[...]


Panel:International Diabetes Federation: metabolic syndrome definition

Central obesity
Waist circumference*—ethnicity specific

Table: Ethnic-specific values for waist circumference
Ethnic group Waist circumference
(as measure of central obesity)
Europids* Men94 cm Women80 cm
South Asians Men90 cm Women80 cm
Chinese Men90 cm Women80 cm
Japanese Men85 cm Women90 cm
Ethnic south and central Americans Use south Asian recommendations until
more specific data are available
Sub-Saharan Africans Use European data until more specific data are
available
Eastern Mediterranean and middle east (Arab) populations Use European data
until more specific data are available
Data are pragmatic cutoffs and better data are required to link them to
risk. Ethnicity should be basis for classification, not country of
residence. *In USA, Adult Treatmen panel III values (102 cm male, 88 cm
female) are likely to continue to be used for clinical purposes. In future
epidemiological studies of populations of Europid origin (white people of
European origin, regardless of where they live in the world),
prevalence should be given, with both European and North American cutoffs
to allow better comparisons.




Plus any two:

Raised triglycerides150 mg/dL (1·7 mmol/L)
Specific treatment for this lipid abnormality

Reduced HDL-cholesterol40 mg/dL (1·03 mmol/L) in men50 mg/dL (1·29 mmol/L)
in women
Specific treatment for this lipid abnormality

Raised blood pressure
Systolic 130 mm Hg
Diastolic 85 mm Hg
Treatment of previously diagnosed hypertension

Raised fasting plasma glucoseâ€*
Fasting plasma glucose 100 mg/dL (5·6 mmol/L)
Previously diagnosed type 2 diabetes
If above 5·6 mmol/L or 100 mg/dL, oral glucose tolerance test is strongly
recommended, but is not necessary to define presence of syndrome

*If body-mass index is over 30 kg/m , central obesity can be assumed and
waist circumference does not need to be
measured. â€*In clinical practice, impaired glucose tolerance is also
acceptable, but all reports of prevalence of metabolic
syndrome should use only fasting plasma glucose and presence of previously
diagnosed diabetes to define hyperglycaemia. Prevalences also incorporating
2-h glucose results can be added as supplementary findings.

[...]

Lancet, Vol 366, September 24, 2005



xpost sci.med.nutrition,sci.med.cardiology,misc.health.d iabetes

How's the job, Andy?

TC

Andrew B. Chung, MD/PhD wrote:
The smaller the waistline the better especially for those with
metabolic syndrome (MetS) which includes everyone with type-2 diabetes.

May GOD continue to heal our hearts with HIS living water so that we
can love others just a little bit more, dear brother Enrico whom I love
unconditionally.

Prayerfully in Christ's amazing love,

Andrew
--
Andrew B. Chung
Cardiologist, Atlanta, Georgia, USA
http://HeartMDPhD.com/HolySpirit

As for knowing who are the very elect, these you will know by the
unconditional love they have for everyone including their enemies
(Matthew 5:44-45, 1 Corinthians 13:3, James 2:14-17).
http://HeartMDPhD.com/Love


Enrico C wrote:
94cm = 37inches
80cm = 31/32inches


What do you make of this...?

http://www.ucdmc.ucdavis.edu/ome/mcr...definition.pdf

The metabolic syndrome—a new worldwide definition
[...]
The International Diabetes Federation (IDF) felt there
was a strong need for one practical definition that would
be useful in any country for the identification of people at
high risk of CVD, but also diabetes. This definition would
also allow comparative long-term studies, which could
then be used, if necessary, to refine the definition on the
basis of solid endpoints. As a result, an IDF consensus
group met in 2004, with representatives from the
organisations that had generated the previous definitions
and members from all IDF regions. Their recommenda-
tions are now available.
[...]
Central obesity, as assessed by waist circumference, was
agreed as essential (panel), because of the strength of the
evidence linking waist circumference with cardiovascular
disease and the other metabolic syndrome components,
and the likelihood that central obesity is an early step in
the aetiological cascade leading to full metabolic
syndrome. The waist circumference cutoff selected was
the same as that used by European Group for the Study of
Insulin Resistance, and lower than the main Adult
Treatment Panel III recommendations, because most
available data suggest an increase in other cardiovascular
disease risk factors in Europids (white people of European
origin, regardless of where they live in the world) when
the waist circumference rises above 94 cm in men and
80cm in women. Ethnic-specific waist circumference
cutoffs have been incorporated into the definition (table),
and have been based on available data linking waist
circumference to other components of the metabolic
syndrome in different populations. The levels of the
other variables were as described by Adult Treatment
Panel III, except that the most recent diagnostic level from
the American Diabetes Association for impaired fasting
glucose (5·6 mmol/L [100 mg/dL]) was used. Although
this new definitionwill still miss substantial numbers of
people with impaired glucose tolerance (because an oral
glucose-tolerance test is not required), it retains the
simplicity of the instrument.
The consensus group also recommended additional
criteria that should be part of further research into
metabolic syndrome, including: tomographic assessment
of visceral adiposity and liver fat, biomarkers of adipose
tissue (adiponectin, leptin), apolipoprotein B, LDL particle
size, formal measurement of insulin resistance and an oral
glucose-tolerance test, endothelial dysfunction, urinary
albumin, inflammatory markers (C-reactive protein,
tumour necrosis factor , interleukin 6), and thrombotic
markers (plasminogen activator inhibitor type 1,
fibrinogen). These factors should be combined with
assessment of CVD outcome and development of
diabetes so better predictors can be developed.
Researchers and clinicians should use the new criteria
for the identification of high-risk individuals and for
research studies. Preventive measures are obviously
needed in the people identified. Mounting evidence
suggests that lifestyle modification with weight loss and
increased physical activity will be beneficial, although
specific studies in metabolic syndrome are needed.
[...]


Panel:International Diabetes Federation: metabolic syndrome definition

Central obesity
Waist circumference*—ethnicity specific

Table: Ethnic-specific values for waist circumference
Ethnic group Waist circumference
(as measure of central obesity)
Europids* Men94 cm Women80 cm
South Asians Men90 cm Women80 cm
Chinese Men90 cm Women80 cm
Japanese Men85 cm Women90 cm
Ethnic south and central Americans Use south Asian recommendations until
more specific data are available
Sub-Saharan Africans Use European data until more specific data are
available
Eastern Mediterranean and middle east (Arab) populations Use European data
until more specific data are available
Data are pragmatic cutoffs and better data are required to link them to
risk. Ethnicity should be basis for classification, not country of
residence. *In USA, Adult Treatmen panel III values (102 cm male, 88 cm
female) are likely to continue to be used for clinical purposes. In future
epidemiological studies of populations of Europid origin (white people of
European origin, regardless of where they live in the world),
prevalence should be given, with both European and North American cutoffs
to allow better comparisons.




Plus any two:

Raised triglycerides150 mg/dL (1·7 mmol/L)
Specific treatment for this lipid abnormality

Reduced HDL-cholesterol40 mg/dL (1·03 mmol/L) in men50 mg/dL (1·29 mmol/L)
in women
Specific treatment for this lipid abnormality

Raised blood pressure
Systolic 130 mm Hg
Diastolic 85 mm Hg
Treatment of previously diagnosed hypertension

Raised fasting plasma glucoseâ€*
Fasting plasma glucose 100 mg/dL (5·6 mmol/L)
Previously diagnosed type 2 diabetes
If above 5·6 mmol/L or 100 mg/dL, oral glucose tolerance test is strongly
recommended, but is not necessary to define presence of syndrome

*If body-mass index is over 30 kg/m , central obesity can be assumed and
waist circumference does not need to be
measured. â€*In clinical practice, impaired glucose tolerance is also
acceptable, but all reports of prevalence of metabolic
syndrome should use only fasting plasma glucose and presence of previously
diagnosed diabetes to define hyperglycaemia. Prevalences also incorporating
2-h glucose results can be added as supplementary findings.

[...]

Lancet, Vol 366, September 24, 2005



xpost sci.med.nutrition,sci.med.cardiology,misc.health.d iabetes

On 5 Dec 2006 09:33:24 -0800, wrote:

How's the job, Andy?

Would you at least quit quoting the quack when you respond to his
bait? Some of us have him killfiled...

WoolyGooly wrote:
On 5 Dec 2006 09:33:24 -0800, wrote:

How's the job, Andy?

Would you at least quit quoting the quack when you respond to his
bait? Some of us have him killfiled...

sorry